PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Royal Recognition as Peli BioThermal is Officially Presented with Queen’s Award for International Export Expertise

Lord-Lieutenant Helen Nellis Conducts Official Presentation Proceedings at UK Headquarters
Leaders from Peli BioThermal, the global name in temperature controlled packaging, were joined by business officials and distinguished dignitaries at an esteemed presentation ceremony at the company’s UK headquarters to celebrate the company’s second successive Queen’s Award win. The award was granted for exceptional growth of product revenue manufactured and designed in the UK, but primarily sold to customers in Europe, Asia and the Americas.
Peli BioThermal leadership team members Fiona Adams, Director of Worldwide Finance and Paul Terry, Director of Sales EMEA, were initially welcomed to a winners’ regal reception at Buckingham Palace where they met His Royal Highness, the Prince of Wales, who personally congratulated them on the company’s award success. Following Peli BioThermal’s Palace visit an official award presentation took place at the company’s UK offices in Leighton Buzzard, Bedfordshire.
The Peli BioThermal team welcomed Her Majesty the Queen’s representative for Bedfordshire, the Lord-Lieutenant Helen Nellis, who conducted the official presentation proceedings.
David Williams, president of Peli BioThermal said: “It is an incredible privilege and honour for the company to receive a second Queen’s Award for Enterprise. It is all the more prestigious as this is the second Queen’s Award we have received in a row”.
“Following our previous award for Innovation, for our pioneering single use shipper Chronos™ Advance, it is another remarkable achievement to again receive royal recognition for International Trade and export expertise”,explains Williams.“This second successive award acknowledges Peli BioThermal’s outstanding overseas sales performance providing the life sciences industry with thermal protection packaging solutions for the safe transportation of pharmaceuticals globally.”
The official presentation of the Queen’s Award for Enterprise, the UK’s most prestigious business awards recognised globally, was officiated by the Lord-Lieutenant, who congratulated the celebrating company on its award win saying: “This is a very significant achievement. It was only last year I was here presenting the award for Innovation and I am so proud of you for achieving the International Trade award so soon after. At Peli BioThermal you can all be really proud of your outstanding achievements in the last few years.”
CEO of corporate parent, Pelican Products, Lyndon Faulkner, added: “This is a remarkable achievement to again be the proud recipients of a second Queen’s Award and demonstrates Pelican’s ongoing dedication to providing our global customers with award-winning products and services.”
The judging panel highlighted how the company’s “introduction of a reusable and rental product range, offers significant customer return on investment and the ability to obtain and use products at short notice, but without investing large sums of money upfront.
Major markets include Benelux, Central America and the Far East. Overseas sales have grown by 122% over the last three years and 61% of sales is exported. The company wins the Queen’s Award for International Trade for Outstanding Short Term Growth in overseas sales over the last three years.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026